GROVE MEDICAL CENTRE
THE GROVE, EGHAMSTIA007
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 31 | 34 | 91.2% | |
STROKE 9 | 2006 | 44 | 45 | 97.8% | |
Stroke 12 | 2007 | 49 | 50 | 98.0% | |
Stroke 12 | 2008 | 54 | 60 | 90.0% | |
Stroke 12 | 2009 | 53 | 60 | 88.3% | |
Stroke 12 | 2010 | 66 | 70 | 94.3% | |
STROKE 12 | 2011 | 68 | 75 | 90.7% | |
STROKE 12 | 2012 | 70 | 77 | 90.9% | |
STROKE 12 | 2013 | 75 | 82 | 91.5% | |
STIA007 | 2014 | 80 | 82 | 97.6% | |
STIA007 | 2015 | 87 | 88 | 98.9% | |
STIA007 | 2016 | 94 | 96 | 97.9% | |
STIA007 | 2017 | 100 | 102 | 98.0% | |
STIA007 | 2018 | 119 | 122 | 97.5% | |
STIA007 | 2019 | 118 | 121 | 97.5% | |
STIA007 | 2020 | 113 | 117 | 96.6% | |
STIA007 | 2021 | 122 | 138 | 88.4% | |
STIA007 | 2022 | 134 | 141 | 95.0% | |
STIA007 | 2023 | 155 | 159 | 97.5% |